MS: Busting the Myths
April 24, 2025 | Advocacy, Life with MS, News, Treatments
Photo by Kristine Wook, Unsplash. Medsafe have approved the registration of Ocrevus ® Subcutaneous (SC) (ocrelizumab and hyaluronidase) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). The announcement on […]
March 27, 2025 | Advocacy, Event, Media, News, Treatments
Watch MSNZ President, Neil Woodhams, on TVNZ Breakfast today where he calls for Pharmac to fund 4 new drugs for MS treatment. Neil Woodhams attended this interview ahead of us appearing at Parliament later this morning, with the Bangers to Bluff […]
March 27, 2025 | Advocacy, Media, News, Press Release, Treatments
There are calls for Pharmac to “quit stalling” and fund four affordable treatments to significantly improve quality of life for patients with Multiple Sclerosis (MS) in New Zealand – treatments which would also significantly reduce demand on New Zealand’s stretched […]
February 25, 2025 | Advocacy, News, Treatments
Over the last decade, we have seen the needs of people with MS are changing. This is largely due to the availability of higher efficacy DMTs in NZ, and ever-advancing research is also telling us even more about the importance […]
February 24, 2025 | Advocacy, News
Recently, Multiple Sclerosis New Zealand (MSNZ) wrote to Pharmac to express our immense disappointment with their Health Technologies Assessment (HTA) process, the treatment funding assessment process, and the impact this is having on the MS community. The varicella zoster virus, […]